Sufentanil sublingual tablet system for the management of postoperative pain

Rovnat Babazade, Alparslan Turan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: Intravenous patient-controlled opioid analgesia has been an important improvement in addressing insufficient management of acute postoperative pain for over 40 years. However, there are number of weaknesses for intravenous patient-controlled analgesia, including operator and device error, intravenous line patency issues, and risk of catheter-related infection, all of which contribute to the complications and increase in cost of care. The sublingual sufentanil tablet system is a major evolution in both drug and technological management of postoperative pain. Areas covered: We reviewed the use of the sublingual sufentanil tablet system in management of moderate to severe postoperative pain in hospitalized patients, with a particular focus on the pharmacological properties of sufentanil and clinical use in different surgical patients. Expert opinion: The sublingual sufentanil tablet system can decrease intravenous opioid based patient-controlled analgesia related complications and safety issues. Current clinical studies have demonstrated this noninvasive-novel system to be safe and effective in management of acute pain in the postsurgical setting. Researchers should focus on comparing it with other available patient controlled analgesia modalities and evaluating the efficiency and cost effectiveness of the sublingual sufentanil tablet system.

Original languageEnglish (US)
Pages (from-to)2351-2357
Number of pages7
JournalExpert Opinion on Pharmacotherapy
Volume17
Issue number17
DOIs
StatePublished - Nov 21 2016

Fingerprint

Sufentanil
Postoperative Pain
Patient-Controlled Analgesia
Tablets
Acute Pain
Opioid Analgesics
Catheter-Related Infections
Expert Testimony
Cost-Benefit Analysis
Research Personnel
Pharmacology
Safety
Costs and Cost Analysis
Equipment and Supplies
Pharmaceutical Preparations

Keywords

  • Patient-controlled analgesia
  • postoperative pain
  • sublingual sufentanil treatment system
  • sufentanil
  • sufentanil metabolism

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Sufentanil sublingual tablet system for the management of postoperative pain. / Babazade, Rovnat; Turan, Alparslan.

In: Expert Opinion on Pharmacotherapy, Vol. 17, No. 17, 21.11.2016, p. 2351-2357.

Research output: Contribution to journalArticle

@article{8bf478f116d4448bb0e6f90f3aa7667a,
title = "Sufentanil sublingual tablet system for the management of postoperative pain",
abstract = "Introduction: Intravenous patient-controlled opioid analgesia has been an important improvement in addressing insufficient management of acute postoperative pain for over 40 years. However, there are number of weaknesses for intravenous patient-controlled analgesia, including operator and device error, intravenous line patency issues, and risk of catheter-related infection, all of which contribute to the complications and increase in cost of care. The sublingual sufentanil tablet system is a major evolution in both drug and technological management of postoperative pain. Areas covered: We reviewed the use of the sublingual sufentanil tablet system in management of moderate to severe postoperative pain in hospitalized patients, with a particular focus on the pharmacological properties of sufentanil and clinical use in different surgical patients. Expert opinion: The sublingual sufentanil tablet system can decrease intravenous opioid based patient-controlled analgesia related complications and safety issues. Current clinical studies have demonstrated this noninvasive-novel system to be safe and effective in management of acute pain in the postsurgical setting. Researchers should focus on comparing it with other available patient controlled analgesia modalities and evaluating the efficiency and cost effectiveness of the sublingual sufentanil tablet system.",
keywords = "Patient-controlled analgesia, postoperative pain, sublingual sufentanil treatment system, sufentanil, sufentanil metabolism",
author = "Rovnat Babazade and Alparslan Turan",
year = "2016",
month = "11",
day = "21",
doi = "10.1080/14656566.2016.1254190",
language = "English (US)",
volume = "17",
pages = "2351--2357",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "17",

}

TY - JOUR

T1 - Sufentanil sublingual tablet system for the management of postoperative pain

AU - Babazade, Rovnat

AU - Turan, Alparslan

PY - 2016/11/21

Y1 - 2016/11/21

N2 - Introduction: Intravenous patient-controlled opioid analgesia has been an important improvement in addressing insufficient management of acute postoperative pain for over 40 years. However, there are number of weaknesses for intravenous patient-controlled analgesia, including operator and device error, intravenous line patency issues, and risk of catheter-related infection, all of which contribute to the complications and increase in cost of care. The sublingual sufentanil tablet system is a major evolution in both drug and technological management of postoperative pain. Areas covered: We reviewed the use of the sublingual sufentanil tablet system in management of moderate to severe postoperative pain in hospitalized patients, with a particular focus on the pharmacological properties of sufentanil and clinical use in different surgical patients. Expert opinion: The sublingual sufentanil tablet system can decrease intravenous opioid based patient-controlled analgesia related complications and safety issues. Current clinical studies have demonstrated this noninvasive-novel system to be safe and effective in management of acute pain in the postsurgical setting. Researchers should focus on comparing it with other available patient controlled analgesia modalities and evaluating the efficiency and cost effectiveness of the sublingual sufentanil tablet system.

AB - Introduction: Intravenous patient-controlled opioid analgesia has been an important improvement in addressing insufficient management of acute postoperative pain for over 40 years. However, there are number of weaknesses for intravenous patient-controlled analgesia, including operator and device error, intravenous line patency issues, and risk of catheter-related infection, all of which contribute to the complications and increase in cost of care. The sublingual sufentanil tablet system is a major evolution in both drug and technological management of postoperative pain. Areas covered: We reviewed the use of the sublingual sufentanil tablet system in management of moderate to severe postoperative pain in hospitalized patients, with a particular focus on the pharmacological properties of sufentanil and clinical use in different surgical patients. Expert opinion: The sublingual sufentanil tablet system can decrease intravenous opioid based patient-controlled analgesia related complications and safety issues. Current clinical studies have demonstrated this noninvasive-novel system to be safe and effective in management of acute pain in the postsurgical setting. Researchers should focus on comparing it with other available patient controlled analgesia modalities and evaluating the efficiency and cost effectiveness of the sublingual sufentanil tablet system.

KW - Patient-controlled analgesia

KW - postoperative pain

KW - sublingual sufentanil treatment system

KW - sufentanil

KW - sufentanil metabolism

UR - http://www.scopus.com/inward/record.url?scp=84996552020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996552020&partnerID=8YFLogxK

U2 - 10.1080/14656566.2016.1254190

DO - 10.1080/14656566.2016.1254190

M3 - Article

VL - 17

SP - 2351

EP - 2357

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 17

ER -